Ms. Thompson is a health policy and reimbursement strategist with extensive experience working with governmental agencies, private payers, Congressional leaders, and patient advocacy groups to improve patient access to existing and new medical therapies. She has more than 15 years of leadership experience in health care, including the ability to develop strategic and tactical recommendations to ensure optimal reimbursement for products.

Tamar currently serves as director of payer relations for Health Diagnostic Laboratory (HDL) where she is responsible for building relationships and collaborating with payers, providers, and employers to create innovative disease management solutions for cardiovascular disease. Prior to joining HDL, Tamar was a strategic policy advisor and consultant for two Washington DC based firms, Kimbell & Associates and Avalere Health, where she managed a diverse portfolio of clients, including medical device, biotech, pharmaceutical, and specialty drug companies. Preceding her time in Washington DC, Ms. Thompson was Director of Health Policy & Reimbursement at Molecular Insight Pharmaceuticals (MIP), charged with developing and launching reimbursement strategy for cutting-edge molecular diagnostic and therapeutic treatments options. Ms. Thompson also spent many years in the managed care sector (Humana and ValueOptions) where she was responsible for claims operations and benefit plan management.

Ms. Thompson holds a M.S. in Health Sciences with a concentration in Public Health. She also has active certifications from the American Health Information Management Association (AHIMA) as a Certified Coding Specialist (CCS) and Certified Coding Specialist – Physician Based (CCS-P).